Markets:

Overview

News

Currencies

International

Treasuries

Actuate Therapeutics, Inc. - Common stock (NQ:ACTU)

2.531 +0.261 (+11.50%)

Streaming Delayed Price Updated: 12:02 PM EDT, Apr 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics: Poised for Potential $200M+ Pediatric Priority Review Vouchers and Transformative Combinations in RAS-Driven Cancers

March 24, 2026

Via ACCESS Newswire

Actuate Therapeutics Stock Rises After Updating FDA Application For Lead Investigational Drug In Treating Pancreatic Cancer ↗

September 22, 2025

Actuate on Monday also said that its recent $17.25 million public offering provides an extended runway into the second half of 2026.

Via Stocktwits

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 09, 2025

Via Benzinga

This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday ↗

August 26, 2025

Via Benzinga

Actuate Therapeutics Advances a New Era in Oncology with Potential Universal Backbone Therapy

August 25, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 26, 2025

Via Benzinga

Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket ↗

January 28, 2025

Via Benzinga

Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

December 13, 2024

Via Benzinga

Pheton, Powell Max Make Public Debut ↗

September 08, 2024

Pheton Holdings and Powell Max opened for trading on Thursday at $3.76 and $4.30, respectively. While the number of initial public offerings has rebounded from 2023, IPOs remain well below pre-pandemic...

Via Talk Markets

Actuate Therapeutics Makes Public Debut ↗

August 18, 2024

Actuate Therapeutics opened on Aug. 13 at $9.88. The biopharmaceutical company had priced its initial public offering of 2.8 million shares at a price of $8.00 per share.

Via Talk Markets

InvestorNewsBreaks – Actuate Therapeutics, Inc. (NASDAQ: ACTU) Closes on $22.4M Initial Public Offering

August 15, 2024

Via Investor Brand Network

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.